HomeICCC • NASDAQ
add
ImmuCell Corp
Previous close
$5.57
Day range
$5.64 - $5.74
Year range
$4.32 - $7.60
Market cap
51.06M USD
Avg Volume
19.32K
P/E ratio
21.81
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 5.51M | -8.41% |
Operating expense | 2.34M | 8.55% |
Net income | -139.75K | 80.08% |
Net profit margin | -2.54 | 78.23% |
Earnings per share | — | — |
EBITDA | 699.16K | 597.57% |
Effective tax rate | -3.29% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.89M | 2.04% |
Total assets | 45.73M | 2.88% |
Total liabilities | 15.93M | -11.69% |
Total equity | 29.80M | — |
Shares outstanding | 9.05M | — |
Price to book | 1.69 | — |
Return on assets | 0.11% | — |
Return on capital | 0.11% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -139.75K | 80.08% |
Cash from operations | -1.18M | -84.97% |
Cash from investing | -592.02K | -569.62% |
Cash from financing | -337.69K | -110.51% |
Net change in cash | -2.11M | -185.02% |
Free cash flow | -1.95M | -341.45% |
About
Founded
1982
Headquarters
Website
Employees
81
